PURPOSE: The purpose of this study was to assess the interval cancer (IC) proportional incidence and review IC cases observed in an Italian mammography screening programme during 2000-2006. MATERIALS AND METHODS: ICs were identified through linkage of a screening database with the local cancer registry and hospital discharge records to calculate proportional (observed/expected) incidence. Negatively reported mammograms preceding ICs underwent blind review (randomly mixed with negative controls in a 2:1 ratio) by three expert radiologists and classified according to European guidelines criteria (OC=occult, MS=minimal sign, SE=screening error) according to majority report. Proportional IC incidence and rate of reviewed IC classified as SE were compared with European guideline standards. RESULTS: Proportional IC incidence was 10.8% in the first and 40.0% in the second year of the interval (European standard=30% or 50%, respectively). Sensitivity estimate for the 2-year interval was 74.6%. ICs were reviewed as SE, MS or OC in 15.0%, 14.0% or 71.0% of cases, respectively. Corresponding review results for negative controls were 7.0%, 25.0% or 68.0%, respectively. Positive predictive value for IC was 51.7% for SE and 21.8% for MS reporting category, respectively (p=0.008). European standard (<20% reviewed as SE) was reached. CONCLUSIONS: The study shows that the sensitivity of the mammography programme was good, complying with European guideline recommendations. Assessment of IC-based early indicators of screening efficacy is feasible in a current screening programme and should become a routine procedure.
PURPOSE: The purpose of this study was to assess the interval cancer (IC) proportional incidence and review IC cases observed in an Italian mammography screening programme during 2000-2006. MATERIALS AND METHODS: ICs were identified through linkage of a screening database with the local cancer registry and hospital discharge records to calculate proportional (observed/expected) incidence. Negatively reported mammograms preceding ICs underwent blind review (randomly mixed with negative controls in a 2:1 ratio) by three expert radiologists and classified according to European guidelines criteria (OC=occult, MS=minimal sign, SE=screening error) according to majority report. Proportional IC incidence and rate of reviewed IC classified as SE were compared with European guideline standards. RESULTS: Proportional IC incidence was 10.8% in the first and 40.0% in the second year of the interval (European standard=30% or 50%, respectively). Sensitivity estimate for the 2-year interval was 74.6%. ICs were reviewed as SE, MS or OC in 15.0%, 14.0% or 71.0% of cases, respectively. Corresponding review results for negative controls were 7.0%, 25.0% or 68.0%, respectively. Positive predictive value for IC was 51.7% for SE and 21.8% for MS reporting category, respectively (p=0.008). European standard (<20% reviewed as SE) was reached. CONCLUSIONS: The study shows that the sensitivity of the mammography programme was good, complying with European guideline recommendations. Assessment of IC-based early indicators of screening efficacy is feasible in a current screening programme and should become a routine procedure.
Authors: Rossella Burani; Francesco Caimi; Carlo Maggioni; Guia Marinoni; Romana Pellizzoni; Maria Elena Pirola; Roberto Villa; Stefano Ciatto Journal: Radiol Med Date: 2005-03 Impact factor: 3.469
Authors: R Mariotto; B Brancato; F Bonetti; E Manfrin; M Strabbioli; A Mercanti; F Falsirollo; P Bricolo; G F Pistolesi Journal: Radiol Med Date: 2007-03-19 Impact factor: 3.469
Authors: D Bernardi; M Pellegrini; S Di Michele; P Tuttobene; C Fantò; M Valentini; M Gentilini; S Ciatto Journal: Radiol Med Date: 2012-01-07 Impact factor: 3.469
Authors: S Ciatto; D Bernardi; M Pellegrini; G Borsato; P Peterlongo; M A Gentilini; F Caumo; A Frigerio; N Houssami Journal: Eur Radiol Date: 2011-12-27 Impact factor: 5.315
Authors: M Pellegrini; D Bernardi; S Di Michele; P Tuttobene; C Fantò; M Valentini; P Peterlongo; F Caumo; A Frigerio; S Ciatto Journal: Radiol Med Date: 2011-07-09 Impact factor: 3.469